Insider trades
Frank Stokes, Director of Exagen XGN, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $717.4K. The latest trade was on 06/09.
Frank Stokes
Director
- Company
- Exagen XGN
- First filing
- 23/04/05
- Trades
- 61 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$717.4K
- Last trade
- 06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/05 | 03/09 | 6,001 sh | $27.98 | $167,907.98 | −9.1% | |
CSTL | Open-market sale10b5-1 plan | 03/03 | 03/05 | 7,000 sh2 trades | $27.44avg. | $192,073 | −11.8% |
| Open-market sale | 25/12/11 | 25/12/15 | 4,496 sh | $37.45 | $168,375.2 | −8.2% | |
| Open-market sale10b5-1 plan | 25/11/11 | 25/11/13 | 5,388 sh | $35.08 | $189,011.04 | −11.1% | |
| Open-market sale10b5-1 plan | 25/02/20 | 25/02/24 | 8,046 sh | $26.70 | $214,828.2 | −18.6% | |
CSTL | Open-market sale10b5-1 plan | 24/11/15 | 24/11/19 | 6,923 sh2 trades | $29.93avg. | $207,214.01 | −18.3% |
CSTL | Open-market sale10b5-1 plan | 24/08/07 | 24/08/13 | 10,000 sh2 trades | $25.70avg. | $257,022 | −24.5% |
